Want to see BTSG full AI Analyst Report?
BTSG Stock Chart & Stats
$47.27
-$0.12(-0.69%)
At close: 4:00 PM EST
$47.27
-$0.12(-0.69%)
Day’s Range― - ―
52-Week Range$19.01 - $70.72
Previous CloseN/A
Volume351.53K
Average Volume (3M)3.21M
Market Cap
$13.54B
Enterprise Value$14.46B
Total Cash (Recent Filing)$888.80M
Total Debt (Recent Filing)$2.70B
Price to Earnings (P/E)45.4
Beta1.10
Next Earnings
Jul 31, 2026EPS Estimate
0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.52
Shares Outstanding196,258,400
10 Day Avg. Volume4,248,568
30 Day Avg. Volume3,213,692
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)4.05
Price to Sales (P/S)0.59
P/FCF Ratio19.22
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue1.06
Enterprise Value/Gross Profit8.70
Enterprise Value/Ebitda27.42
Forecast
1Y Price Target
$68.64Price Target Upside45.20% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)1.69
Revenue Forecast (FY)$15.06B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow GenerationConsistent trailing‑twelve‑month free cash flow roughly matching net income (~0.99x) provides durable internal funding for capex, integration of acquisitions, and debt paydown. This cash conversion supports balance sheet repair and strategic investments without heavy reliance on external capital.
Balance Sheet ImprovementMaterial reduction in leverage from prior elevated levels (>1.5) to pro‑forma ~2.27x net debt and a stronger equity base enhances financial flexibility. Lower leverage sustains lower interest burden and gives the company room to invest in growth, M&A integration and withstand reimbursement cycles.
Pharmacy Specialty & Infusion MomentumRobust specialty and infusion growth reflects structural demand for complex therapies and sticky customer relationships. Faster script growth, high medication possession and efficient fill times support scalable, higher‑value revenue that can drive sustainable margin improvement and competitive differentiation.
Bears Say
Regulatory & Market Reimbursement HeadwindsSubstantial, multi‑component reimbursement pressures (IRA and brand‑to‑generic conversions) create a structural revenue and gross‑profit drag. These policy and market shifts can erode core pharmacy economics over multiple years, forcing ongoing offsetting actions or permanent margin sacrifice.
Thin Operating MarginsRelatively low gross and EBITDA margins leave limited buffer against cost inflation, reimbursement cuts, or integration hiccups. Sustaining profitability requires continuous efficiency gains and scale benefits; otherwise, modest adverse changes can materially depress earnings and free cash flow.
PBM / Payer Competitive DynamicsOngoing PBM and payer strategies to direct volume to captive or preferred providers are a structural industry risk. Over time this can reduce access to payor networks, pressure pricing and volumes, and compel higher commercial investment or margin concessions to retain share.
BrightSpring Health Services, Inc. News
BTSG FAQ
What was BrightSpring Health Services, Inc.’s price range in the past 12 months?
BrightSpring Health Services, Inc. lowest stock price was $19.01 and its highest was $70.72 in the past 12 months.
What is BrightSpring Health Services, Inc.’s market cap?
BrightSpring Health Services, Inc.’s market cap is $13.54B.
When is BrightSpring Health Services, Inc.’s upcoming earnings report date?
BrightSpring Health Services, Inc.’s upcoming earnings report date is Jul 31, 2026 which is in 30 days.
How were BrightSpring Health Services, Inc.’s earnings last quarter?
BrightSpring Health Services, Inc. released its earnings results on May 01, 2026. The company reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.309 by $0.081.
Is BrightSpring Health Services, Inc. overvalued?
According to Wall Street analysts BrightSpring Health Services, Inc.’s price is currently Undervalued.
Does BrightSpring Health Services, Inc. pay dividends?
BrightSpring Health Services, Inc. does not currently pay dividends.
What is BrightSpring Health Services, Inc.’s EPS estimate?
BrightSpring Health Services, Inc.’s EPS estimate is 0.4.
How many shares outstanding does BrightSpring Health Services, Inc. have?
BrightSpring Health Services, Inc. has 196,258,400 shares outstanding.
What happened to BrightSpring Health Services, Inc.’s price movement after its last earnings report?
BrightSpring Health Services, Inc. reported an EPS of $0.39 in its last earnings report, beating expectations of $0.309. Following the earnings report the stock price went up 9.61%.
Which hedge fund is a major shareholder of BrightSpring Health Services, Inc.?
Currently, no hedge funds are holding shares in BTSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BrightSpring Health Services, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$68.64 (45.20% Upside)
$68.64 (45.20% Upside)
Blogger Sentiment
Bullish
BTSG Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.5M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.2%
Last 30 Days ▲ 19.9%
Last 30 Days ▲ 19.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
193.03%
12-Months-Change
Fundamentals
Return on Equity
12.71%
Trailing 12-Months
Asset Growth
6.27%
Trailing 12-Months
Company Description
BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists. Formerly known as Phoenix Parent Holdings Inc., the company officially adopted the name BrightSpring Health Services, Inc. in May 2021. Founded in 1974, its headquarters are located in Louisville, Kentucky.
BTSG Company Deck
BTSG Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented strong operational and financial momentum: double-digit revenue growth, a 45% increase in adjusted EBITDA, improved margins, solid segment performance in specialty, infusion and home health, successful integration contributions, and a meaningful cash proceeds event to strengthen the balance sheet. These positives are tempered by clear, quantified headwinds from IRA impacts and brand-to-generic conversions (~$600M aggregate headwind referenced), a Q1 rise in corporate investments, and ongoing PBM/payer competitive dynamics. Management characterized the headwinds as expected and actionable and reiterated guidance, suggesting confidence in execution and mitigation plans.View all BTSG earnings summariesBTSG Stock 12 Month Forecast
Average Price Target
$68.64
▲(45.20% Upside)
Technical Analysis
Ownership Overview
44.32% Insiders
29.70% Mutual Funds
5.39% Other Institutional Investors
0.94% Public Companies and Individual Investors